About Ed Hurwitz
Ed Hurwitz is a director at Arialys Therapeutics.
Ed Hurwitz first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Ed Hurwitz in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ed Hurwitz works with at each company, as listed on that company's latest Form D.
Arialys Therapeutics, Inc. · Form D, Jul 1, 2025
JD
Jay Lichter, Ph.D.
Director
PD
Peter Flynn, Ph.D.
Chief Executive Officer and director
BH
AD
Ashish Xavier, Ph.D.
Director